Ballentine Carter H 2012 Differentiation of lethal and non lethal prostate

Ballentine carter h 2012 differentiation of lethal

This preview shows page 4 - 5 out of 5 pages.

Ballentine-Carter, H. (2012). Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics. Asian Journal Of Andrology , 14 (3), 355-360. doi: 10.1038/aja.2011.141 Ball, J. W., Dains, J. E., Flynn, J. A., Solomon, B. S., & Stewart, R. W. (2019). Seidel's guide to physical examination: An interprofessional approach (9th ed.). St. Louis, MO: Elsevier Mosby. Carter, H. (2018). Prostate-Specific Antigen (PSA) Screening for Prostate Cancer. JAMA , 319 (18), 1866. doi: 10.1001/jama.2018.4914 Chaudhary, M., & Nisar, A. (2017). Escalating Health Care Cost due to Unnecessary Diagnostic Testing. Mehran University Research Journal Of Engineering And Technology , 36 (3), 569-578. doi: 10.22581/muet1982.1703.13 Descotes, J., 2019. Diagnosis of prostate cancer. Asian Journal of Urology , 6(2), pp.129-136. Eastham, J. (2017). Prostate cancer screening. Investigative And Clinical Urology , 58 (4), 217. doi: 10.4111/icu.2017.58.4.217 4
Image of page 4
Assessment Tools and Diagnostic Tests in Adults and Children Ilic, D., Djulbegovic, M., Jung, J., Hwang, E., Zhou, Q., & Cleves, A. et al. (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta- analysis. BMJ , k3519. doi: 10.1136/bmj.k3519 Palsdottir, T., Nordstrom, T., Karlsson, A., Grönberg, H., Clements, M., & Eklund, M. (2019). The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study. BMJ Open , 9 (3), e027958. doi: 10.1136/bmjopen-2018- 027958 Tikkinen, K., Dahm, P., Lytvyn, L., Heen, A., Vernooij, R., Siemieniuk, R., Wheeler, R., Vaughan, B., Fobuzi, A., Blanker, M., Junod, N., Sommer, J., Stirnemann, J., Yoshimura, M., Auer, R., MacDonald, H., Guyatt, G., Vandvik, P. and Agoritsas, T., 2018. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline. BMJ , p.k3581. Zolot, J. (2017). Study Finds Overall Prostate Cancer Mortality Decreases with PSA Screening. AJN, American Journal Of Nursing , 117 (12), 16. doi: 10.1097/01.naj.0000527472.38965.1f 5
Image of page 5

You've reached the end of your free preview.

Want to read all 5 pages?

  • Fall '18
  • Prostate cancer, Prostate-specific antigen

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture